Infection Drugs News

News

Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe | PRLog
www.prlog.org | Feb 12, 2012
Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe. The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe. - PR11796726

Call to scrap "misleading" GP antibiotic measures | 6minutes
www.6minutes.com.au | Feb 9, 2012
One of the government’s key performance indicators for GPs – the prescribing of antibiotics for common colds – is highly misleading and should be scrapped, epidemiologists say.

Sanofi France Announces FDA Approval of Sklice
www.biospace.com | Feb 8, 2012
BRIDGEWATER, N.J., Feb. 7, 2012 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration has approved Sklice® lotion, 0.5% for

GlaxoSmithKline plc's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com | Feb 7, 2012
< p > GlaxoSmithKline plc ( < a href='http://seekingalpha.com/symbol/gsk' title='GlaxoSmithKline' > GSK < /a > ) < /p > < p > Q4 2011 Earnings Call < /p > < p > February 07, 2012 9:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > Andrew Witty - Chief Executive Officer,

Short Antibiotic Courses Safer for Breathing-Tube Infections in Children - 05/05/2011
www.hopkinsmedicine.org | Jan 27, 2012
Short courses of antibiotics appear just as effective as longer ones — and a great deal safer — in treating respiratory infections that might cause pneumonia in children on temporary breathing devices, according to a Johns Hopkins Children’s Center study published online May 3 in Clinical

Growth of Vaccines Calls for Better, Faster Production | SYS-CON MEDIA
www.sys-con.com | Jan 19, 2012
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

HHS and Novartis Dedicate First Cell-Based Flu Vaccine Plant in US - Pharmaceutical Technology
pharmtech.findpharma.com | Jan 6, 2012
Last week, the US Department of Health and Human Services and Novartis Vaccines and Diagnostics dedicated a manufacturing plant that can create influenza vaccine using cultured animal cells instead of the conventional expression system of fertilized eggs.

Approaches for Flexible Manufacturing Facilities in Vaccine Production - With careful analysis to
biopharminternational.findpharma.com | Jan 6, 2012
With careful analysis to mitigate risk, disposable technology and process closure can enable adaptable designs and reduced costs.

Promising results in mice on needle-free candidate universal vaccine against various flu viruses
www.sciencedaily.com | Dec 22, 2011
Scientists have discovered that an antigen common to most influenza viruses, and commonly referred to as matrix protein 2, when administered under the tongue could protect mice against experimental infection caused by various influenza viruses, including the highly pathogenic avian H5 virus and the

amednews: Physicians are paid less to give combination vaccines :: Dec. 21, 2011 ... American
www.ama-assn.org | Dec 21, 2011
Researchers say administering a single injection takes as much time as separate ones because patients need to be counseled about the immunizations.